ST Josephs University Medical Center INC.

ST Josephs University Medical Center INC. was paid $322.40M by Medicaid between Jan 2018 and Dec 2024, across 746 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.

33Billing provider infoST JOSEPHS UNIVERSITY MEDICAL CENTER INC.
PATERSON, NJ 07503

33aNPI1669462420assigned 10/24/2005

33bProvider typeClinic/Center

28Total paid$322.40M

24GClaims4,731,861

24DCodes billed746

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinic/Center providers in New Jersey

Rank by total paid#1 of 97

Median peer was paid$318K

This provider vs. median1,014×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	603,637	$47.89M
2019	632,399	$45.29M
2020	527,375	$37.52M
2021	642,288	$44.18M
2022	764,757	$46.86M
2023	840,071	$49.11M
2024incomplete	721,334	$51.55M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	18%	168,032	148,694	$59.30M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	17%	182,234	165,521	$53.84M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	10%	67,020	58,716	$33.37M
G0378	Hospital observation service, per hour	2.5%	11,466	9,643	$7.99M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.2%	34,752	32,417	$7.01M
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	1.7%	51,437	31,040	$5.61M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.6%	8,990	8,661	$5.13M
H0035	Mental health partial hospitalization, treatment, less than 24 hours	1.5%	20,079	1,618	$4.83M
S9480	Intensive outpatient psychiatric services, per diem	1.4%	5,576	5,218	$4.58M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.2%	10,635	10,115	$3.93M
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.2%	29,176	26,210	$3.73M
70450	Computed tomography, head or brain; without contrast material	1.1%	26,623	24,152	$3.48M

734 more codes

U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.0%	56,993	$3.35M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.0%	19,414	$3.33M
OP710		<1%	17,138	$3.22M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	85,753	$3.21M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	5,604	$2.80M
A0427	Emergency ambulance ride, advanced life support	<1%	11,598	$2.75M
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	23,328	$2.66M
99213	Doctor's office visit, returning patient (routine)	<1%	54,156	$2.60M
96375	Therapeutic injection; each additional sequential IV push	<1%	37,912	$2.51M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	109,418	$2.50M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	39,719	$2.46M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	58,873	$2.43M
59025	Fetal non-stress test	<1%	11,904	$2.38M
41899	Unlisted procedure, dentoalveolar structures	<1%	1,884	$2.34M
OP272		<1%	29,882	$2.26M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	53,095	$2.26M
80053	Comprehensive metabolic panel	<1%	155,476	$2.21M
96361	Intravenous infusion, hydration; each additional hour	<1%	40,970	$2.19M
93458		<1%	1,196	$2.04M
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	14,990	$1.96M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	20,829	$1.93M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	944	$1.91M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	2,928	$1.78M
93017		<1%	8,570	$1.76M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,567	$1.63M
99214	Doctor's office visit, returning patient (more involved)	<1%	24,005	$1.58M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	193,777	$1.54M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	17,329	$1.46M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	20,197	$1.35M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,745	$1.32M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	28,732	$1.30M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	5,608	$1.29M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,985	$1.26M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	3,037	$1.25M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	24,939	$1.18M
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	36,369	$1.11M
76818		<1%	8,697	$1.09M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	14,574	$1.07M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	8,935	$1.05M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	20,351	$977K
OP250		<1%	276,555	$966K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	5,001	$964K
76830	Ultrasound, transvaginal	<1%	9,292	$939K
71046	Radiologic examination, chest; 2 views	<1%	52,880	$914K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	13,676	$887K
47562		<1%	366	$833K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,021	$818K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	46,152	$778K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	826	$751K
81422		<1%	1,157	$691K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,573	$658K
71045	Radiologic examination, chest; single view	<1%	48,729	$657K
92587		<1%	6,540	$631K
70486		<1%	3,545	$613K
93970		<1%	3,325	$611K
90791	Psychiatric diagnostic evaluation	<1%	4,487	$601K
71250		<1%	3,367	$580K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,797	$567K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	853	$554K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,348	$548K
93971		<1%	5,914	$541K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	17,410	$502K
76641		<1%	6,006	$493K
73564		<1%	10,704	$487K
72125	Computed tomography, cervical spine; without contrast material	<1%	5,210	$482K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	13,648	$463K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	26,135	$448K
93975		<1%	2,321	$437K
93798		<1%	10,541	$434K
95782		<1%	198	$420K
76819	Fetal biophysical profile; without non-stress testing	<1%	4,443	$412K
58558		<1%	395	$411K
80048	Basic metabolic panel (calcium, ionized)	<1%	37,866	$409K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	29,107	$408K
88342		<1%	9,578	$394K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	1,227	$390K
76770		<1%	3,960	$389K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,263	$381K
77063	Screening digital breast tomosynthesis, bilateral	<1%	10,701	$380K
76801		<1%	2,686	$376K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	16,562	$370K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,143	$365K
78815	Positron emission tomography (PET) for limited area imaging	<1%	510	$361K
97161		<1%	8,486	$360K
93880		<1%	2,065	$327K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	11,182	$320K
77080		<1%	5,144	$316K
76536		<1%	3,654	$312K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,074	$306K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	5,427	$301K
81025		<1%	84,672	$300K
90792	Psychiatric diagnostic evaluation with medical services	<1%	3,293	$295K
86900		<1%	30,869	$294K
73630		<1%	11,361	$278K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	5,450	$270K
73130		<1%	9,876	$268K
92579		<1%	2,234	$257K
73610		<1%	11,195	$255K
84484		<1%	54,892	$253K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	7,361	$249K
77066	Tomosynthesis, mammo	<1%	2,329	$243K
86850		<1%	24,658	$243K
74183		<1%	428	$232K
44970		<1%	144	$232K
92557		<1%	1,709	$229K
72110		<1%	5,611	$215K
81001		<1%	88,358	$214K
86901		<1%	31,080	$210K
36415	Collection of venous blood by venipuncture	<1%	105,190	$208K
73030		<1%	9,289	$207K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	168	$206K
92567		<1%	4,340	$202K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,635	$202K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	14,001	$196K
96415		<1%	1,366	$195K
81412		<1%	1,277	$193K
73110		<1%	7,695	$190K
88313		<1%	9,257	$188K
76870		<1%	2,467	$178K
36430		<1%	2,295	$171K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	141	$168K
96409		<1%	703	$168K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	8,639	$168K
94644		<1%	5,599	$162K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	32,512	$161K
87086	Culture, bacterial; quantitative colony count, urine	<1%	39,173	$160K
97165		<1%	2,989	$159K
77065	Tomosynthesis, mammo	<1%	2,350	$158K
92610		<1%	1,701	$154K
82962		<1%	50,477	$152K
92582		<1%	1,328	$151K
76775		<1%	2,134	$151K
84443	Thyroid stimulating hormone (TSH)	<1%	12,890	$146K
76813		<1%	1,829	$146K
85730		<1%	23,696	$144K
10060		<1%	1,906	$143K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	16,311	$142K
72131		<1%	1,619	$141K
76377		<1%	2,895	$140K
73590		<1%	5,375	$140K
12011		<1%	1,754	$139K
99203	Doctor's office visit, new patient (routine)	<1%	2,620	$136K
J3490	Unclassified drugs	<1%	67,854	$136K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	17,233	$136K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,644	$134K
70491		<1%	609	$134K
12001		<1%	2,167	$133K
97014		<1%	20,234	$133K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,022	$133K
83690		<1%	37,295	$133K
76820		<1%	2,915	$131K
74178		<1%	546	$130K
96417		<1%	630	$130K
94375		<1%	2,299	$130K
96367		<1%	4,128	$130K
84702		<1%	14,668	$129K
99215	Doctor's office visit, returning patient (complex)	<1%	1,960	$129K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	8,650	$127K
94726		<1%	2,791	$124K
83735		<1%	29,400	$121K
73080		<1%	4,899	$119K
97162		<1%	2,243	$119K
99381		<1%	1,821	$116K
80061	Lipid panel	<1%	12,936	$114K
92523		<1%	1,560	$111K
C1874	Stent, coated/covered, with delivery system	<1%	265	$110K
99204	Doctor's office visit, new patient (more involved)	<1%	1,978	$110K
73700		<1%	905	$109K
96376		<1%	3,553	$109K
A9270	Non-covered item or service	<1%	20,698	$106K
72082		<1%	1,932	$106K
75574		<1%	368	$104K
90715		<1%	10,135	$104K
85027		<1%	14,954	$103K
74018		<1%	4,205	$102K
A0425	Ground mileage, per statute mile	<1%	11,616	$102K
94729		<1%	2,675	$101K
A0998	Ambulance response and treatment, no transport	<1%	734	$100K
85610		<1%	27,963	$100K
83036	Hemoglobin; glycosylated (A1C)	<1%	12,544	$99K
73090		<1%	4,834	$99K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	4,613	$98K
83880		<1%	8,978	$96K
92550		<1%	2,832	$96K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	5,154	$96K
72050		<1%	2,355	$95K
J2704	Injection, propofol, 10 mg	<1%	26,271	$94K
87070		<1%	15,755	$90K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,357	$89K
73560		<1%	2,683	$89K
76642		<1%	1,775	$88K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	70	$87K
A0433	Advanced life support, level 2 (als 2)	<1%	278	$87K
86703		<1%	6,231	$87K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,355	$86K
93925		<1%	413	$85K
90837	Psychotherapy session, about an hour	<1%	6,098	$84K
C1769	Guide wire	<1%	3,164	$82K
88307		<1%	1,577	$82K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	16,829	$81K
95886		<1%	1,049	$80K
70544		<1%	582	$79K
73502		<1%	4,119	$79K
95708		<1%	500	$78K
72100		<1%	2,394	$77K
90472	Immunization administration, each additional vaccine (list separately)	<1%	12,386	$77K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	72	$76K
94060		<1%	399	$75K
73140		<1%	3,767	$74K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	175	$74K
C1781	Mesh (implantable)	<1%	80	$74K
95816		<1%	455	$73K
72170		<1%	2,424	$71K
86481		<1%	909	$71K
86360		<1%	1,731	$70K
72141		<1%	359	$70K
87490		<1%	4,011	$70K
87522	Neg quan hep c or qual rna	<1%	4,013	$69K
72197		<1%	130	$68K
92586		<1%	613	$67K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,590	$66K
87535		<1%	1,371	$64K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	79,103	$62K
97803		<1%	1,090	$61K
54161		<1%	59	$61K
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	342	$60K
70498		<1%	687	$60K
83021		<1%	3,182	$60K
94010		<1%	373	$59K
88304		<1%	3,246	$59K
77062		<1%	1,169	$57K
29515		<1%	1,202	$56K
87040		<1%	6,751	$56K
73552		<1%	2,377	$56K
90838		<1%	972	$55K
76000		<1%	1,890	$55K
92651		<1%	705	$53K
82728		<1%	6,607	$53K
OP258		<1%	27,054	$52K
J7030	Infusion, normal saline solution , 1000 cc	<1%	38,210	$52K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	810	$52K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	454	$51K
85044		<1%	10,466	$51K
77072		<1%	1,540	$51K
87186		<1%	8,809	$50K
87077		<1%	9,391	$50K
81003		<1%	26,123	$50K
77336		<1%	684	$49K
76821		<1%	808	$48K
12002		<1%	884	$48K
70496		<1%	674	$48K
94664		<1%	1,013	$48K
84439		<1%	5,091	$48K
73060		<1%	2,383	$47K
C1760	Closure device, vascular (implantable/insertable)	<1%	658	$46K
81222		<1%	141	$46K
29125		<1%	1,158	$45K
80076		<1%	7,083	$45K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	135	$44K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,774	$44K
90686		<1%	14,382	$43K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	921	$43K
52000		<1%	69	$42K
83605		<1%	7,282	$42K
82077		<1%	8,020	$41K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	44,130	$41K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,453	$41K
95700		<1%	581	$41K
C1889	Implantable/insertable device, not otherwise classified	<1%	39	$39K
83615		<1%	7,869	$39K
J1756	Injection, iron sucrose, 1 mg	<1%	1,812	$39K
74019		<1%	1,362	$38K
82607		<1%	5,304	$37K
84100		<1%	14,167	$36K
OP270		<1%	4,825	$35K
J1630	Injection, haloperidol, up to 5 mg	<1%	5,346	$35K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,441	$35K
73521		<1%	1,035	$35K
95812		<1%	105	$34K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	577	$33K
97535	Self-care/home management training, each 15 minutes	<1%	1,121	$33K
87536		<1%	439	$33K
52356		<1%	13	$33K
66982		<1%	40	$33K
97164		<1%	761	$32K
J2060	Injection, lorazepam, 2 mg	<1%	5,158	$32K
S9484	Crisis intervention mental health services, per hour	<1%	39	$32K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	5,027	$30K
71101		<1%	1,512	$30K
87483		<1%	232	$30K
80320		<1%	6,213	$30K
87807		<1%	1,581	$29K
96523		<1%	228	$29K
J1815	Injection, insulin, per 5 units	<1%	1,280	$29K
95953		<1%	28	$28K
92526		<1%	604	$28K
86803		<1%	2,175	$28K
74240		<1%	296	$27K
76981		<1%	421	$27K
83540		<1%	6,129	$27K
OP271		<1%	4,080	$26K
87081		<1%	3,019	$26K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,535	$26K
94770		<1%	539	$26K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,053	$26K
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	29	$25K
94727		<1%	960	$25K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	23,066	$25K
88142		<1%	1,221	$25K
72072		<1%	959	$25K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	723	$25K
97022		<1%	2,868	$24K
81329		<1%	207	$22K
82105		<1%	2,186	$22K
99205	Prolong outpt/office vis	<1%	222	$22K
97035		<1%	4,112	$22K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	15,566	$22K
81243		<1%	427	$22K
86923		<1%	963	$22K
90651		<1%	1,967	$22K
97802		<1%	270	$21K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	473	$21K
86592		<1%	6,458	$20K
92611		<1%	138	$20K
88341		<1%	371	$20K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	241	$20K
93296		<1%	1,373	$20K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	19,771	$20K
90681		<1%	3,300	$19K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	11,441	$19K
82947		<1%	2,986	$19K
Q3014	Telehealth originating site facility fee	<1%	8,796	$19K
83655		<1%	1,583	$18K
76885		<1%	290	$18K
95908		<1%	333	$18K
49591		<1%	12	$18K
95910		<1%	181	$18K
73562		<1%	455	$18K
G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	<1%	30	$18K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,059	$18K
74021		<1%	791	$17K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	185	$17K
94645		<1%	668	$17K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	4,733	$17K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	3,261	$16K
A4649	Surgical supply; miscellaneous	<1%	6,881	$16K
73000		<1%	610	$15K
82746		<1%	2,191	$15K
96127		<1%	1,296	$15K
80329		<1%	2,112	$15K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	310	$15K
85379		<1%	4,732	$14K
87088		<1%	3,964	$14K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	2,255	$14K
36600		<1%	2,115	$14K
77061		<1%	773	$14K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	914	$14K
87590		<1%	702	$14K
92551		<1%	406	$14K
72132		<1%	159	$14K
86140		<1%	4,150	$13K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	742	$13K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	1,645	$13K
85660		<1%	3,269	$13K
97116		<1%	920	$13K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	6,404	$13K
G0390	Trauma response team associated with hospital critical care service	<1%	35	$13K
82550		<1%	3,896	$12K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	14,593	$12K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	141	$12K
72128		<1%	131	$12K
82248		<1%	2,713	$12K
J1170	Injection, hydromorphone, up to 4 mg	<1%	7,542	$12K
85651		<1%	6,842	$11K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,829	$11K
15853		<1%	433	$11K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,590	$11K
86762		<1%	2,472	$11K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	9,153	$11K
95813		<1%	65	$11K
87623		<1%	316	$11K
0001A		<1%	415	$10K
76937		<1%	267	$10K
93325		<1%	54	$10K
95957		<1%	31	$10K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	498	$10K
82570		<1%	2,560	$10K
87205		<1%	3,051	$10K
84436		<1%	867	$10K
90474		<1%	2,705	$10K
90670		<1%	3,944	$10K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	93	$9K
J7050	Infusion, normal saline solution, 250 cc	<1%	4,631	$9K
82803		<1%	467	$9K
90734		<1%	1,171	$9K
80164		<1%	834	$9K
93226		<1%	52	$9K
93299		<1%	381	$9K
J1644	Injection, heparin sodium, per 1000 units	<1%	3,956	$9K
72129		<1%	95	$9K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,070	$9K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	11,753	$8K
82043		<1%	1,979	$8K
29130		<1%	170	$8K
0072A		<1%	271	$8K
82150		<1%	2,047	$8K
83970		<1%	345	$8K
A9505	Thallium tl-201 thallous chloride, diagnostic, per millicurie	<1%	252	$8K
90677		<1%	1,886	$8K
97166		<1%	135	$8K
0002A		<1%	314	$8K
72040		<1%	477	$8K
88312		<1%	454	$8K
84550		<1%	2,655	$8K
0071A		<1%	284	$8K
70360		<1%	383	$8K
73200		<1%	52	$7K
36591		<1%	473	$7K
92555		<1%	181	$7K
99173		<1%	384	$7K
74220		<1%	153	$7K
86704		<1%	969	$7K
80179		<1%	1,201	$7K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	313	$7K
86706		<1%	846	$7K
93225		<1%	53	$7K
82247		<1%	1,669	$7K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	125	$7K
85347		<1%	1,016	$6K
87147		<1%	1,343	$6K
74230		<1%	125	$6K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	1,772	$6K
OP278		<1%	13	$6K
86141		<1%	997	$6K
0004A		<1%	217	$6K
D0140	Limited oral evaluation - problem focused	<1%	2,833	$6K
97163		<1%	122	$6K
J3370	Injection, vancomycin hcl, 500 mg	<1%	798	$5K
99417	Prolong home eval add 15m	<1%	92	$5K
93312		<1%	12	$5K
76376		<1%	233	$5K
90675		<1%	108	$5K
83520		<1%	502	$5K
82784		<1%	687	$5K
0042T		<1%	78	$5K
29705		<1%	71	$5K
86920		<1%	98	$5K
96368		<1%	234	$5K
0054A		<1%	204	$5K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	893	$5K
86902		<1%	130	$5K
J3590	Unclassified biologics	<1%	455	$5K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	163	$5K
87420		<1%	239	$5K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	3,506	$5K
82009		<1%	2,069	$5K
81002		<1%	2,587	$4K
88300		<1%	771	$4K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	85	$4K
86038		<1%	411	$4K
19083		<1%	16	$4K
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	313	$4K
87075		<1%	845	$4K
87184		<1%	344	$4K
95885		<1%	76	$4K
90723		<1%	4,823	$4K
74022		<1%	120	$4K
51701		<1%	99	$4K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	410	$4K
70490		<1%	33	$4K
92015	Determination of refractive state	<1%	622	$4K
J1790	Injection, droperidol, up to 5 mg	<1%	1,400	$4K
90620		<1%	939	$4K
76001		<1%	38	$3K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	12	$3K
J3360	Injection, diazepam, up to 5 mg	<1%	626	$3K
76881		<1%	42	$3K
84156		<1%	2,048	$3K
87902		<1%	14	$3K
OP229		<1%	61	$3K
84153		<1%	313	$3K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	4,921	$3K
J1940	Injection, furosemide, up to 20 mg	<1%	1,376	$3K
51702		<1%	132	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,047	$3K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	99	$3K
81514		<1%	15	$3K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	16	$3K
J9370	Vincristine sulfate, 1 mg	<1%	226	$3K
82805		<1%	121	$3K
73660		<1%	158	$3K
78264		<1%	39	$3K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	6,344	$3K
80299		<1%	170	$3K
45381		<1%	14	$3K
87350		<1%	443	$3K
74170		<1%	13	$3K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	28	$3K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	293	$3K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	80	$3K
94761		<1%	83	$2K
90375		<1%	15	$2K
88346		<1%	41	$2K
D7140	Extraction, erupted tooth or exposed root	<1%	665	$2K
73070		<1%	142	$2K
77334		<1%	15	$2K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	26	$2K
86707		<1%	426	$2K
87641		<1%	135	$2K
V2632	Posterior chamber intraocular lens	<1%	226	$2K
87430		<1%	351	$2K
86705		<1%	517	$2K
93924		<1%	15	$2K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	37	$2K
86870		<1%	81	$2K
75625		<1%	15	$2K
76857		<1%	75	$2K
97168		<1%	45	$2K
86787		<1%	192	$2K
76506		<1%	26	$2K
82397		<1%	108	$2K
0124A		<1%	89	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	530	$2K
71271		<1%	28	$2K
86922		<1%	41	$2K
0011A		<1%	62	$2K
82657		<1%	80	$2K
A9585	Injection, gadobutrol, 0.1 ml	<1%	179	$2K
96167		<1%	720	$2K
86256		<1%	31	$2K
86769		<1%	73	$2K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	20	$2K
90714		<1%	123	$2K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	32	$2K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	103	$2K
82274		<1%	485	$2K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	25	$2K
92556		<1%	25	$2K
90649		<1%	88	$2K
D1120	Dental cleaning, child	<1%	864	$2K
87340		<1%	338	$2K
C1758	Catheter, ureteral	<1%	197	$2K
J1953	Injection, levetiracetam, 10 mg	<1%	508	$2K
72070		<1%	53	$2K
70355		<1%	95	$2K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,339	$2K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	663	$2K
J1245	Injection, dipyridamole, per 10 mg	<1%	239	$2K
84145		<1%	219	$1K
87899		<1%	222	$1K
82951		<1%	132	$1K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	88	$1K
90707		<1%	1,050	$1K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	409	$1K
80074		<1%	57	$1K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	453	$1K
C1780	Lens, intraocular (new technology)	<1%	102	$1K
90716		<1%	1,207	$1K
59020		<1%	25	$1K
92522		<1%	28	$1K
92060		<1%	67	$1K
87507		<1%	15	$1K
86580		<1%	263	$1K
86003		<1%	26	$1K
84480		<1%	148	$1K
86480		<1%	71	$1K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	103	$1K
82330		<1%	201	$1K
D0220	Intraoral - periapical first radiographic image	<1%	1,549	$1K
J3535	Drug administered through a metered dose inhaler	<1%	433	$1K
85014		<1%	177	$1K
93321		<1%	12	$1K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	325	$1K
76882		<1%	36	$1K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	247	$1K
82731		<1%	17	$1K
D0330	Panoramic radiographic image	<1%	685	$1K
86696		<1%	44	$993.38
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	159	$989.62
84703		<1%	374	$979.10
G0466	Community health center visit, new patient	<1%	12	$958.02
29530		<1%	18	$932.61
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	817	$929.01
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	62	$928.64
84132		<1%	534	$926.38
0064A		<1%	35	$906.36
78306		<1%	12	$898.22
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	42	$875.75
90732		<1%	28	$849.36
71100		<1%	28	$835.11
C1753	Catheter, intravascular ultrasound	<1%	33	$820.90
41800		<1%	13	$803.81
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	31	$798.47
82977		<1%	147	$780.16
86695		<1%	46	$777.06
C1729	Catheter, drainage	<1%	55	$769.42
96156		<1%	164	$739.14
0346T		<1%	12	$729.20
31575		<1%	12	$727.44
29540		<1%	12	$717.65
93280		<1%	54	$715.72
82575		<1%	95	$711.04
90674		<1%	152	$695.80
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	24	$686.51
64400		<1%	14	$677.61
20610		<1%	16	$662.06
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	143	$638.44
90633		<1%	2,412	$610.81
12013		<1%	12	$580.50
D1206	Topical application of fluoride varnish	<1%	138	$577.80
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	41	$573.11
87338		<1%	183	$561.82
C1885	Catheter, transluminal angioplasty, laser	<1%	13	$512.54
74248		<1%	12	$509.56
90656		<1%	253	$508.13
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	660	$507.24
J3250	Injection, trimethobenzamide hcl, up to 200 mg	<1%	82	$505.84
80185		<1%	53	$476.95
97018		<1%	186	$472.78
88302		<1%	29	$459.11
89051		<1%	180	$457.59
D0120	Dental checkup, returning patient	<1%	360	$446.26
J0173	Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg	<1%	148	$442.06
86708		<1%	129	$436.99
70160		<1%	13	$428.68
0134A		<1%	21	$424.50
90700		<1%	1,001	$420.62
86694		<1%	26	$417.36
S5571	Insulin delivery device, disposable pen (including insulin); 3 ml size	<1%	29	$416.12
87046		<1%	70	$409.31
86665		<1%	21	$407.56
80177		<1%	81	$402.26
75710		<1%	15	$382.58
J0461	Injection, atropine sulfate, 0.01 mg	<1%	116	$378.27
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	498	$364.64
J9260	Injection, methotrexate sodium, 50 mg	<1%	64	$362.10
15854		<1%	14	$349.25
0052A		<1%	12	$345.10
84295		<1%	237	$339.77
D1110	Prophylaxis - adult	<1%	146	$339.00
94762		<1%	15	$335.71
86618		<1%	12	$330.36
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	123	$281.23
93297		<1%	108	$273.37
85240		<1%	13	$264.78
J8597	Antiemetic drug, oral, not otherwise specified	<1%	28	$263.39
87045		<1%	55	$261.24
86308		<1%	72	$258.62
93298		<1%	16	$237.35
J0280	Injection, aminophyllin, up to 250 mg	<1%	472	$236.99
J1171	Injection, hydromorphone, 0.1 mg	<1%	160	$235.74
82375		<1%	49	$231.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	70	$230.66
J3480	Injection, potassium chloride, per 2 meq	<1%	168	$221.52
D9310		<1%	606	$220.00
86317		<1%	46	$218.42
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	25	$211.12
86777		<1%	13	$204.72
86664		<1%	12	$203.12
0051A		<1%	14	$193.58
D1208	Topical application of fluoride, excluding varnish	<1%	418	$177.35
90688		<1%	26	$173.76
D0274	Bitewings - four radiographic images	<1%	70	$170.82
82378		<1%	13	$170.40
84311		<1%	37	$169.03
89230		<1%	12	$168.15
86663		<1%	12	$163.71
83516		<1%	30	$157.22
90473		<1%	49	$149.55
G0008	Administration of influenza virus vaccine	<1%	406	$138.18
69209		<1%	12	$134.57
90756		<1%	16	$124.54
90662		<1%	17	$113.62
87449		<1%	13	$110.61
85246		<1%	13	$108.88
36000		<1%	13	$105.74
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	73	$105.73
82945		<1%	54	$96.89
90685		<1%	31	$95.01
90647		<1%	4,284	$93.60
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	142	$91.95
88112		<1%	13	$84.87
86431		<1%	13	$78.73
82533		<1%	13	$76.75
90619		<1%	78	$75.34
87185		<1%	27	$74.41
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	12	$73.49
82360		<1%	13	$72.96
86880		<1%	14	$67.30
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	12	$65.80
88311		<1%	14	$65.77
D0150	Comprehensive oral evaluation - new or established patient	<1%	29	$64.00
90648		<1%	13	$62.76
J7510	Prednisolone oral, per 5 mg	<1%	53	$61.46
82785		<1%	13	$58.51
84157		<1%	55	$57.43
J0290	Injection, ampicillin sodium, 500 mg	<1%	46	$56.31
87106		<1%	14	$50.60
85060		<1%	15	$48.30
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	88	$40.37
91300		<1%	645	$39.00
J0571	Buprenorphine, oral, 1 mg	<1%	23	$38.62
J0456	Injection, azithromycin, 500 mg	<1%	18	$37.07
A4550	Surgical trays	<1%	68	$33.11
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	<1%	39	$33.00
D0270		<1%	38	$31.00
84481		<1%	13	$30.00
D0230	Intraoral - periapical each additional radiographic image	<1%	60	$26.60
A6250	Skin sealants, protectants, moisturizers, ointments, any type, any size	<1%	21	$19.32
J0694	Injection, cefoxitin sodium, 1 gm	<1%	16	$17.11
86709		<1%	13	$11.97
83930		<1%	13	$11.36
OP279		<1%	51	$10.01
91307		<1%	446	$9.00
91305		<1%	317	$5.00
91301		<1%	92	$3.00
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	<1%	33	$2.00
OP259		<1%	31	$1.84
D9222		0%	61	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	21	$0.00
91303		0%	63	$0.00
90696		0%	182	$0.00
90381		0%	78	$0.00
D0240		0%	12	$0.00
D9223	Deep sedation/general anesthesia - each subsequent 15 minute increment	0%	31	$0.00
D7240	Removal of impacted tooth - completely bony	0%	13	$0.00
90744		0%	17	$0.00
D0210	Intraoral - complete series of radiographic images	0%	27	$0.00
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	0%	14	$0.00
90710		0%	369	$0.00
90380		0%	88	$0.00
90671		0%	124	$0.00
91312		0%	86	$0.00
91313		0%	21	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCAULFIELD, CHRISTOPHER (EXECUTIVE DIRECTOR, FINANCE)